EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV

Kusha Davar iD, Devin Clark, Robert M Centor, Fernando Dominguez, Bassam Ghanem, Rachael Lee, Todd C Lee iD, Emily G McDonald iD, Matthew C Phillips, Parham Sendi, Brad Spellberg

Open Forum Infectious Diseases · 04.01.2023 · 10 (1)

DOI: 10.1093/ofid/ofac706 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 29.12.2022. Verfasst von Kusha Davar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, California, USA. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Like all fields of medicine, Infectious Diseases is rife with dogma that underpins much clinical practice. In this study, we discuss 2 specific examples of historical practice that have been overturned recently by numerous prospective studies: traditional durations of antimicrobial therapy and the necessity of intravenous (IV)-only therapy for specific infectious syndromes. These dogmas are based on uncontrolled case series from >50 years ago, amplified by the opinions of eminent experts. In contrast, more than 120 modern, randomized controlled trials have established that shorter durations of therapy are equally effective for many infections. Furthermore, 21 concordant randomized controlled trials have demonstrated that oral antibiotic therapy is at least as effective as IV-only therapy for osteomyelitis, bacteremia, and endocarditis. Nevertheless, practitioners in many clinical settings remain refractory to adopting these changes. It is time for Infectious Diseases to move beyond its history of eminent opinion-based medicine and truly into the era of evidenced-based medicine.

Schlagwörter

Stichwörter der Autor:innen

antibioticdogmaevidenced-based medicineoral antibioticsshorter is better

Autor:innen und Institutionen

  • Los Angeles County + University of Southern California (LAC+USC) Medical Center, Los Angeles, California, USA.
  • Department of Medicine, Birmingham Veterans Affairs (VA) Medical Center, Birmingham, Alabama, Birmingham, Alabama, USA.
  • King Abdulaziz Medical City, Jeddah, Saudi Arabia.
  • Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Division of Infectious Diseases, Department of Medicine, McGill University, Montreal, Canada.
  • Division of General Internal Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Kusha Davar, Todd C Lee, Emily G McDonald

Zitieren

APA

Davar, K., Clark, D., Centor, R. M., Dominguez, F., Ghanem, B., Lee, R., Lee, T. C., McDonald, E. G., Phillips, M. C., Sendi, P., & Spellberg, B. (2023). Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV. Open Forum Infectious Diseases, 10(1). https://doi.org/10.1093/ofid/ofac706

Vancouver

Davar K, Clark D, Centor RM, Dominguez F, Ghanem B, Lee R, et al. Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV. Open Forum Infectious Diseases. 2023;10(1). doi:10.1093/ofid/ofac706

BibTeX
@article{Davar2023,
  author = {Davar, Kusha and Clark, Devin and Centor, Robert M and Dominguez, Fernando and Ghanem, Bassam and Lee, Rachael and Lee, Todd C and McDonald, Emily G and Phillips, Matthew C and Sendi, Parham and Spellberg, Brad},
  title = {Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV},
  journal = {Open Forum Infectious Diseases},
  year = {2023},
  volume = {10},
  number = {1},
  doi = {10.1093/ofid/ofac706}
}
Kostenlos starten →